Listed for reference — companies are not ranked in any particular order.
| Market Size 2024 | US$ 1,733.4 Million |
| Market Size 2031 | US$ 3,477.6 Million |
| CAGR 2025–2031 | 10.5% |
| Segments | By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Immune Checkpoint Inhibitors) | By Indication (Blood Cancer, Lung Cancer, Breast Cancer) | By End User (Hospital Pharmacies, Retail Pharmacies, Online Stores) |
| Geographies | Africa (Egypt, South Africa, Nigeria, and Algeria) |
| Deliverables | Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset |
| Report Code | BMIPUB00033501 |
| Lead Analyst | Krishna Sunthwal — Analyst, Research · View Profile |
Gain actionable insights with 194 pages of in-depth Africa Cancer Targeted Therapy Market, including historical trends, 7-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.